Views & Analysis Making it as an oncology biotech in the UK We speak to R&D experts to find out how oncology biotechs can get the support they need to be successful in the competitive UK ecosystem
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.